tirzepatide risk of cancer and in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis Tirzepatide and Its Potential Links

In weight management, semaglutide is approved for people who have a body mass index (BMI) of 30 or higher or a BMI of 27 or higher with weight-related health conditions like high blood pressure or type 2 diabetes

PlexusDx Compounded Tirzepatide Injection starts at $249 per month and remains flat across all commitment tiersyour dose may increase as needed, but your price won't

Young GLP-1 DrugsDecember 1, 2025 WHO Sets GLP-1 Weight-Loss Drug Guidelines New WHO guidance calls for a worldwide obesity treatment ecosystem to ensure that GLP-1 weight-loss drugs are used fairly Dan Vergano PharmaceuticalsNovember 24, 2025 GLP-1 Pill Fails to Slow Alzheimers Progression in Clinical Trial Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral semaglutide failed to slow down Alzheimer's progression Lauren J

Maintaining muscle helps protect metabolism and supports better long-term results

Our team maximizes insurance coverage and addresses any semaglutide prior authorization needs, facilitating manufacturer savings programs where applicable